Azurity Pharmaceuticals, Inc.
Wilmington, MA, United States
4
Total Recalls
2
Class I Recalls
0
Ongoing Recalls
Recalls by Azurity Pharmaceuticals, Inc.
FDA Drug
Class I
Terminated
Zenzedi (Dextroamphetamine Sulfate) CII Tablets, USP, 30 mg, 30-count bottle, Rx only, Mfd. for: Arbor Pharmaceuticals, LLC., Atlanta, Georgia, 30328, NDC 24338-856-03
January 4, 2024
Azurity Pharmaceuticals, Inc.
4,662 bottles units
FDA Drug
Class III
Terminated
Eprontia (topiramate) oral solution, 25 mg/mL, 473 mL Bottle, Rx only, Manufactured for: Azurity Pharmaceuticals, Woburn, MA 01801, NDC 52652-9001-1
December 8, 2023
Azurity Pharmaceuticals, Inc.
2,220 bottles units
FDA Drug
Class II
Terminated
Testosterone Cypionate Injection, USP, CIII, 200 mg/mL, packaged in: a) 10 mL multiple-dose vials (NDC 52536-625-10) and b) 1 mL single dose vials (NDC 52536-625-01), Rx only, Mfd for: Wilshire Pharma
February 15, 2023
Azurity Pharmaceuticals, Inc.
a) 16,471 vials; b) 43,096 vials units
FDA Drug
Class I
Terminated
Firvanq (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit, Each Kit Includes: 1 bottle containing 7.7 g Vancomycin Hydrochloride USP, powder for oral solution and 1 bottle containi
August 24, 2021
Azurity Pharmaceuticals, Inc.
2,751 kits units